ZA816712B - 1-ethyl-6-fluoro-1,4-dihydro-4-oxo 7-(1-piperazinyl)-3-quino-line carboxylic acid and metal salts thereof useful in burn therapy - Google Patents

1-ethyl-6-fluoro-1,4-dihydro-4-oxo 7-(1-piperazinyl)-3-quino-line carboxylic acid and metal salts thereof useful in burn therapy

Info

Publication number
ZA816712B
ZA816712B ZA816712A ZA816712A ZA816712B ZA 816712 B ZA816712 B ZA 816712B ZA 816712 A ZA816712 A ZA 816712A ZA 816712 A ZA816712 A ZA 816712A ZA 816712 B ZA816712 B ZA 816712B
Authority
ZA
South Africa
Prior art keywords
piperazinyl
dihydro
oxo
fluoro
ethyl
Prior art date
Application number
ZA816712A
Other languages
English (en)
Inventor
Charles L Fox Jr
Shanta M Modak
Original Assignee
Fox Charles L Jun
Shanta M Modak
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fox Charles L Jun, Shanta M Modak filed Critical Fox Charles L Jun
Publication of ZA816712B publication Critical patent/ZA816712B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicinal Preparation (AREA)
ZA816712A 1980-10-02 1981-09-28 1-ethyl-6-fluoro-1,4-dihydro-4-oxo 7-(1-piperazinyl)-3-quino-line carboxylic acid and metal salts thereof useful in burn therapy ZA816712B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US19330780A 1980-10-02 1980-10-02

Publications (1)

Publication Number Publication Date
ZA816712B true ZA816712B (en) 1983-01-26

Family

ID=22713084

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA816712A ZA816712B (en) 1980-10-02 1981-09-28 1-ethyl-6-fluoro-1,4-dihydro-4-oxo 7-(1-piperazinyl)-3-quino-line carboxylic acid and metal salts thereof useful in burn therapy

Country Status (13)

Country Link
EP (1) EP0049593B1 (da)
JP (1) JPS57183762A (da)
AT (1) ATE21692T1 (da)
AU (1) AU546922B2 (da)
BR (1) BR8106318A (da)
CA (1) CA1208644A (da)
DE (1) DE3175220D1 (da)
DK (1) DK435781A (da)
ES (1) ES8206514A1 (da)
IE (1) IE52125B1 (da)
IL (1) IL63945A (da)
PT (1) PT73750B (da)
ZA (1) ZA816712B (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3142854A1 (de) * 1981-10-29 1983-05-11 Bayer Ag, 5090 Leverkusen 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7-piperazino-chinolin-3-carbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
DE3308908A1 (de) * 1983-03-12 1984-09-13 Bayer Ag, 5090 Leverkusen Bakterizide mittel
DE3318145A1 (de) * 1983-05-18 1984-11-22 Bayer Ag, 5090 Leverkusen 7-amino-1-cyclopropyl-6,8-difluor-1,4-dihydro-4-oxo-3-chinolincarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
US4551456A (en) * 1983-11-14 1985-11-05 Merck & Co., Inc. Ophthalmic use of norfloxacin and related antibiotics
JPS61180771A (ja) * 1985-01-05 1986-08-13 バイエル・アクチエンゲゼルシヤフト 安定な抗バクテリア剤水溶液
FR2595355B1 (fr) * 1986-03-05 1988-11-25 Edmond Pharma Srl Nouveau sel d'argent derive de quinolone, utile notamment comme antibacterien, et sa fabrication
DE3635062A1 (de) * 1986-10-15 1988-04-21 Bayer Ag Neue metallsalze von 1-cyclopropyl-chinoloncarbonsaeuren und diese enthaltende arzneimittel
FR2665635A1 (fr) * 1990-08-10 1992-02-14 Merck Sharp & Dohme Composition pharmaceutique fluide a base d'un complexe metallique et son procede de preparation.
US6200968B1 (en) * 1998-08-06 2001-03-13 Cephalon, Inc. Particle-forming compositions containing fused pyrrolocarbazoles
US6863825B2 (en) 2003-01-29 2005-03-08 Union Oil Company Of California Process for removing arsenic from aqueous streams
JP2008205418A (ja) * 2007-02-19 2008-09-04 Mikio Shimoyama いつでもスイッチ
US8349764B2 (en) 2007-10-31 2013-01-08 Molycorp Minerals, Llc Composition for treating a fluid
IN2012DN00829A (da) * 2009-07-06 2015-06-26 Molycorp Minerals Llc
US9233863B2 (en) 2011-04-13 2016-01-12 Molycorp Minerals, Llc Rare earth removal of hydrated and hydroxyl species
US9975787B2 (en) 2014-03-07 2018-05-22 Secure Natural Resources Llc Removal of arsenic from aqueous streams with cerium (IV) oxide compositions

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS53141286A (en) * 1977-05-16 1978-12-08 Kyorin Seiyaku Kk Novel substituted quinolinecarboxylic acid
JPS5466686A (en) * 1977-09-20 1979-05-29 Dainippon Pharmaceut Co Ltd Quinoline-3-carboxylic acid derivative, its preparation, and pharmaceutical composition containig the same

Also Published As

Publication number Publication date
IL63945A0 (en) 1981-12-31
DK435781A (da) 1982-04-03
ATE21692T1 (de) 1986-09-15
DE3175220D1 (en) 1986-10-02
AU7601081A (en) 1982-04-08
IL63945A (en) 1986-03-31
PT73750B (en) 1983-01-13
ES505941A0 (es) 1982-08-16
EP0049593B1 (en) 1986-08-27
ES8206514A1 (es) 1982-08-16
IE812225L (en) 1982-04-02
AU546922B2 (en) 1985-09-26
CA1208644A (en) 1986-07-29
JPS57183762A (en) 1982-11-12
PT73750A (en) 1981-10-01
IE52125B1 (en) 1987-06-24
EP0049593A1 (en) 1982-04-14
BR8106318A (pt) 1982-06-22

Similar Documents

Publication Publication Date Title
ZA816712B (en) 1-ethyl-6-fluoro-1,4-dihydro-4-oxo 7-(1-piperazinyl)-3-quino-line carboxylic acid and metal salts thereof useful in burn therapy
NO162236C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-cyklopropyl-6-fluor-1,4-dihydro-4-okso-7-(alkyl-1-piperazinyl)-3-kinolinkarboksylsyrer.
EP0013077A3 (en) Glass composition and its use in a therapeutic composition, in a subcutaneous implant or in a fertilizer, algicide, fungicide, or molluscicide
ZA921268B (en) 2-substituted quinolines,processes for their preparation and their use in medicaments
ES8500931A1 (es) Procedimiento para la obtencion de acidos quinoloncarboxilicos
ZA877149B (da)
MY101808A (en) Polycyclic quinoline, naphthyridine and pyrazinopyridine derivatives.
ES2051225A1 (es) Procedimiento de preparacion del acido 1-etil-6-fluoro-7-(pirrol-1-il) -1,4-dihidro-4-oxo-3-quinoleincarboxilico.
AU2039483A (en) Antimicrobial compositions containing 1-ethyl-6-fluoro-1,4- dihydro-4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinoline carboxylic acid or metal salts thereof & silver sulfadiazine
AU4344279A (en) Heat treatment of ferrous metals under controlled atmosphere
ES448933A1 (es) Metodo para preparar nuevos derivados de acidos carboxili- cos.
ES8303367A1 (es) Un procedimiento para la preparacion de un derivado de tetrazol.